NOTES
TO CONDENSED FINANCIAL STATEMENTS
Three
Months Ended March 31, 2021 and 2020 (Unaudited)
(In
thousands, except share and per share amounts)
1.
Basis of Presentation and Liquidity
The
accompanying interim condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”,
or “our”), are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments,
necessary to present fairly our financial position at March 31, 2021 and the results of operations and cash flows for the three months
ended March 31, 2021 and 2020. The balance sheet as of December 31, 2020 is derived from the Company’s audited financial statements.
Certain
information and footnote disclosures normally included in financial statements that have been prepared in accordance with accounting
principles generally accepted in the United States of America have been condensed or omitted pursuant to the rules and regulations of
the Securities and Exchange Commission regarding interim financial reporting. We believe that the disclosures contained in these condensed
financial statements are adequate to make the information presented herein not misleading. For further information, refer to the financial
statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020,
as filed with the Securities and Exchange Commission on March 30, 2021.
The
results of operations for the three months ended March 31, 2021 are not necessarily indicative of the results of operations to be expected
for the full fiscal year ending December 31, 2021.
COVID-19
Considerations
During
the period ended March 31, 2021, the COVID-19 pandemic has impacted our operating results and the Company anticipates a continued
impact for the balance of the year. In addition, the pandemic may cause reduced demand for our products if, for example, the
pandemic results in a recessionary economic environment which negatively effects the consumers who purchase our products. Based on the
recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.
Through March 31, 2021,
the Company has experienced higher transportation expenses as the capacity in the freight market has not kept up with demand. The Company
believes that costs will continue to increase throughout the year. However, mitigation plans are being implemented to manage this risk.
Our
ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend
on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government
and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through March 31, 2021, we maintained
the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating
with our employees and suppliers to do our part in the infection prevention and remain flexible in responding to our customers and suppliers.
However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for
example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our
operations.
Net sales for the period ended March 31, 2021 were up 28% from the prior year period. Through March 31, 2021, we
continue to generate cash flows to meet our short-term liquidity needs, and we expect to maintain access to the capital markets. We have
also not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19
pandemic.
Liquidity
The
accompanying financial statements have been prepared under the assumption that the Company will continue as a going concern. Such assumption
contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the three months ended March
31, 2021, the Company recorded a net loss of $4,507 and used cash in operations of $5,059. As of March 31, 2021, we had a cash balance
of $155 with borrowing capacity of $2,513, a stockholder’s equity of $6,770 and a working capital of $5,698, compared to a cash
balance of $595 with borrowing capacity of $5,166, stockholders’ equity of $10,404 and a working capital of $9,528 at December
31, 2020. Notwithstanding the net loss for the three months ended March 31, 2021, management projects adequate cash from operations and
available line of credit to ensure continuation of the Company as a going concern for at least one year from the date of this quarterly
report.
Historically,
we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible
debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. We have taken decisive
action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating
improved vendor contracts and restructuring our selling prices.
2.
Significant Accounting Policies
Use
of estimates
The
preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date
of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ
from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts, inventory obsolescence,
depreciable lives of property and equipment, analysis of impairments of recorded long-term tangible and intangible assets, realization
of deferred tax assets, accruals for potential liabilities and assumptions made in valuing stock instruments issued for services.
Revenue
Recognition
The
Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers
(“ASC 606”). The underlying principle of ASC 606 is to recognize revenue to depict the transfer of goods or services to customers
at the amount expected to be collected. ASC 606 creates a five-step model that requires entities to exercise judgment when considering
the terms of contract(s), which include (1) identifying the contract or agreement with a customer, (2) identifying our performance obligations
in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance
obligations, and (5) recognizing revenue as each performance obligation is satisfied.
The
Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain
no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed
before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the
customer. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon
shipment from our facilities. The Company’s performance obligations are satisfied at that time.
All
of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment
for customers to derive the expected value from them.
The
Company does not allow for returns, except for damaged products when the damage occurred pre-fulfillment. Damaged product returns have
historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations
and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations.
We assess our contracts and the reasonableness of our conclusions on a quarterly basis.
Loss
per Common Share
Basic
earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number
of shares of common stock outstanding during the period. Diluted earnings (loss) per share is computed by dividing the net income applicable
to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would
have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares
are excluded from the computation when their effect is antidilutive.
For
the periods ended March 31, 2021 and 2020, the calculations of basic and diluted loss per share are the same because potential dilutive
securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:
Schedule of Potentially Dilutive Securities
|
|
March 31,
2021
|
|
|
March 31,
2020
|
|
Convertible note to a related party
|
|
|
-
|
|
|
|
2,266,667
|
|
Warrants
|
|
|
3,362,241
|
|
|
|
6,413,782
|
|
Common stock equivalent of Series A Convertible Preferred stock
|
|
|
37,644
|
|
|
|
37,644
|
|
Common stock issuable
|
|
|
|
|
|
|
350,000
|
|
Unvested restricted common stock
|
|
|
309,082
|
|
|
|
150,000
|
|
Options
|
|
|
11,028,322
|
|
|
|
4,683,380
|
|
Total
|
|
|
14,737,289
|
|
|
|
13,901,473
|
|
The
Series A Convertible Preferred Stock is convertible into Common shares at the rate of 1:4.
Stock
Compensation Expense
The
Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions
for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock
Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense
on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner
as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements
of Operations with classification depending on the nature of the services rendered.
The
fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain
assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future
dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based
on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense
recorded in future periods.
Advertising
Costs
Advertising
costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $349 and $302 for the
three months ended March 31, 2021 and 2020, respectively.
Concentrations
Gross
sales. During the three months ended March 31, 2021, the Company’s two largest customers accounted for 23% and 12% of gross
sales, respectively. During the three months ended March 31, 2020, the Company’s two largest customers accounted for 22% and 14%
of gross sales, respectively. No other customers exceeded 10% of sales in either period.
Accounts
receivable. As of March 31, 2021, the Company had accounts receivable from two customers which comprised 18% and 10% of its gross
accounts receivable, respectively. As of December 31, 2020, the Company had accounts receivable from one customer which comprised 23%
of its gross accounts receivable. No other customers exceeded 10% of gross accounts receivable in either period.
Purchases
from vendors. During the three months ended March 31, 2021, the Company’s two largest vendor accounted for approximately 13%
and 13% of all purchases, respectively. During the three months ended March 31, 2020, the Company’s largest vendor accounted for
approximately 10% of all purchases. No other vendors exceeded 10% of all purchases in either periods.
Accounts
payable. As of March 31, 2021, the Company’s two largest vendors accounted for 19% and 10% of the total accounts payable, respectively.
As of December 31, 2020 the Company’s largest two vendors accounted for 12% and 10% of the total accounts payable, respectively.
No other vendors exceeded 10% of gross accounts payable in either period.
Fair
Value of Financial Instruments
The
Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring
basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure
their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:
Level
1—Quoted prices in active markets for identical assets or liabilities.
Level
2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.
Level
3—Unobservable inputs based on the Company’s assumptions.
The
carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans,
accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments.
The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates
on these obligations are based on prevailing market interest rates.
Recent
Accounting Pronouncements
In
June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires entities to
use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types
of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13
is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company does not believe the potential impact
of the new guidance and related codification improvements will be material to its financial position, results of operations and cash
flows.
In
August 2020, the FASB issued ASU No. 2020-06 (“ASU 2020-06”) “Debt—Debt with Conversion and Other Options (Subtopic
470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40).” ASU 2020-06 reduces the number
of accounting models for convertible debt instruments by eliminating the cash conversion and beneficial conversion models. The diluted
net income per share calculation for convertible instruments will require the Company to use the if-converted method. For contracts in
an entity’s own equity, the type of contracts primarily affected by this update are freestanding and embedded features that are
accounted for as derivatives under the current guidance due to a failure to meet the settlement conditions of the derivative scope exception.
This update simplifies the related settlement assessment by removing the requirements to (i) consider whether the contract would be settled
in registered shares, (ii) consider whether collateral is required to be posted, and (iii) assess shareholder rights. ASU 2020-06 is
effective January 1, 2024, for the Company and the provisions of this update can be adopted using either the modified retrospective method
or a fully retrospective method. Early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that
year. Effective January 1, 2021, the Company early adopted ASU 2020-06 and that adoption did not have an impact on our financial statements
and related disclosures.
Other
recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants,
and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s
present or future financial statements.
3.
Inventory
Inventory
is valued at the lower of cost (first-in, first-out) or net realizable value, and net of reserves is comprised of the following (in thousands):
Schedule of Inventory
|
|
March 31,
2021
|
|
|
December 31,
2020
|
|
Raw materials and packaging
|
|
$
|
7,746
|
|
|
$
|
6,793
|
|
Finished products
|
|
|
4,699
|
|
|
|
4,326
|
|
Total
|
|
$
|
12,445
|
|
|
$
|
11,119
|
|
The
Company has recorded a reserve for slow moving and potentially obsolete inventory. The reserve at March 31, 2021, and December 31, 2020,
was $174 and $194, respectively.
4.
Property and Equipment
Property
and equipment is comprised of the following (in thousands):
Schedule of Property and Equipment
|
|
March 31,
2021
|
|
|
December 31,
2020
|
|
Right-of-use assets under operating leases
|
|
$
|
724
|
|
|
$
|
724
|
|
Right-of-use assets under finance leases
|
|
|
6
|
|
|
|
54
|
|
Computer hardware and software
|
|
|
400
|
|
|
|
400
|
|
Machinery and equipment
|
|
|
198
|
|
|
|
103
|
|
Total cost
|
|
|
1,328
|
|
|
|
1,281
|
|
Accumulated depreciation and amortization
|
|
|
(379
|
)
|
|
|
(361
|
)
|
Net book value
|
|
$
|
949
|
|
|
$
|
920
|
|
Depreciation
expense for the three months ended March 31, 2021 and 2020 was $32 and $12, respectively, and amortization of right-of-use assets for
the three months ended March 31, 2021 and 2020 was $24 and $37, respectively. During the three months ended March 31, 2021, the Company
disposed of right-of-use assets under finance leases with a cost of $48 and accumulated amortization of $38, and terminated $13 of related
finance leases payable (see Note 8).
Equipment
held for sale consists of the following (in thousands):
Schedule of Equipment Held for Sale
|
|
March 31,
2021
|
|
|
December 31,
2020
|
|
Equipment held for sale
|
|
$
|
163
|
|
|
$
|
163
|
|
Reserve
|
|
|
(96
|
)
|
|
|
(96
|
)
|
Net book value
|
|
$
|
67
|
|
|
$
|
67
|
|
The
balance as of March 31, 2021, and December 31, 2020, consists of residual manufacturing equipment, at estimated net realizable value,
which management anticipates selling during 2021.
5.
Intangible Assets
Intangible
assets are comprised of brand names acquired, specifically Virgil’s, and costs related to trademarks. They have been assigned an
indefinite life, as we currently anticipate that they will contribute cash flows to the Company perpetually. These indefinite-lived intangible
assets are not amortized but are assessed for impairment annually and evaluated annually to determine whether the indefinite useful life
remains appropriate. We first assess qualitative factors to determine whether it is more likely than not that the asset is impaired.
If further testing is necessary, we compare the estimated fair value of our asset with its book value. If the carrying amount of the
asset exceeds its fair value, as determined by the discounted cash flows expected to be generated by the asset, an impairment loss is
recognized in an amount equal to that excess. Based on management’s assessment, there were no indications of impairment at March
31, 2021.
During
the three months ended March 31, 2021, the Company capitalized costs of $2 pertaining to legal and other fees incurred in applying for
international trademarks for Reeds and Virgil’s brands.
Intangible
assets consist of the following (in thousands):
Summary of Intangible Assets
|
|
March 31,
2021
|
|
|
December 31,
2020
|
|
Brand names
|
|
$
|
576
|
|
|
$
|
576
|
|
Trademarks
|
|
|
41
|
|
|
|
39
|
|
Total
|
|
$
|
617
|
|
|
$
|
615
|
|
6.
Line of Credit
Amounts
outstanding under the Company’s credit facilities are as follows (in thousands):
Schedule of Amount Outstanding Under Credit Facilities
|
|
March 31,
2021
|
|
|
December 31,
2020
|
|
Line of credit
|
|
$
|
4,256
|
|
|
$
|
-
|
|
On
October 4, 2018, the Company entered into a financing agreement with Rosenthal & Rosenthal, Inc. The financing agreement provides
a maximum borrowing capacity of $13,000. Borrowings are based on a formula of eligible accounts receivable and inventories (the “permitted
borrowings”) plus advances (an “over-advance” of up to $4,000) in excess of permitted borrowings. At March 31, 2021,
the unused borrowing capacity under the financing agreement was $2,513. The line of credit matured on March 30, 2021, with automatic
yearly renewals thereafter until terminated.
Borrowings
under the Rosenthal financing agreement bear interest at the greater of prime or 4.75%, plus an additional 2.0% to 3.5% depending on
whether the borrowing is based upon receivables, inventory or is an over-advance. Additionally, the line of credit is subject to monthly
facility and administration fees, and aggregate minimum monthly fees (including interest) of $4.
The
line of credit is secured by substantially all of the assets, excluding intellectual property, of the Company. The over-advance is secured
by all of Reed’s intellectual property collateral. Additionally, any over-advance was guaranteed by an irrevocable stand-by letter
of credit in the amount of $1,500, issued by Daniel J. Doherty III and the Daniel J. Doherty, III 2002 Family Trust, affiliates of Raptor/Harbor
Reeds SPV LLC (“Raptor”). On March 11, 2021, the Company entered into an amendment to the financing agreement, releasing
that irrevocable standby letter of credit of $1,500 by Raptor with a $2,000 pledge of securities to Rosenthal by John J. Bello and Nancy
E. Bello, as Co-Trustees of The John and Nancy Bello Revocable Living Trust.
John
J. Bello, current Chairman and former Interim Chief Executive Officer of Reed’s, is a related party. He is also a greater than
5% beneficial owner of Reed’s common stock. As consideration for the collateral support, Mr. Bello received 400,000 shares of Reed’s
restricted stock. The Company determined the fair value of the 400,000 restricted stock to be $472 which was recorded as a prepaid financing
costs and included in prepaid expenses and other current assets on the condensed balance sheet at March 31, 2021. The prepaid financing
fee is to be amortized over a twelve month period. During the three months ended March 31, 2021, the company amortized $25 of the prepaid
financing costs to interest expense.
The
financing agreement with Rosenthal includes customary restrictions that limit our ability to engage in certain types of transactions,
including our ability to utilize tangible and intangible assets as collateral for other indebtedness. Additionally, the agreement contains
a financial covenant that requires us to meet certain minimum working capital and tangible net worth thresholds as of the end of each
quarter. We were in compliance with the terms of our agreement with Rosenthal as of March 31, 2021.
The
Company annually incurs an additional $130 of fees from the bank, which is equal to 1% of the $13,000 borrowing limit. These costs have
been capitalized and recorded as a debt discount and are amortized over the remaining life of the Rosenthal agreement. On December 31,
2020, the remaining unamortized debt discount of $162 is included in prepaid expense and other current assets on the balance sheet. Amortization
of debt discount was $162 and $96 for the three months ended March 31, 2021 and 2020, respectively. On March 31, 2021, no remaining unamortized
debt discount remained.
7.
Note Payable
On
April 20, 2020, the Company was granted a loan (the “PPP loan”) from City National Bank in the aggregate amount of $770,
pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act. At December 31, 2020, the note payable balance
was $770, of which $599 was reflected as the current portion of note payable. At March 31, 2021, the note payable balance was $770, of
which $727 was reflected as the current portion of note payable.
The
PPP loan agreement is dated April 20, 2020, matures on April 20, 2022, bears interest at a rate of 1% per annum, with the first six months
of interest deferred, is payable monthly commencing on November 2020, and is unsecured and guaranteed by the U.S. Small Business Administration.
We applied ASC 470, Debt, to account for the PPP loan. Funds from the PPP loan may only be used for qualifying expenses as described
in the CARES Act, including qualifying payroll costs, qualifying group health care benefits, qualifying rent and debt obligations, and
qualifying utilities. The Company believes it used the entire loan amount for qualifying expenses. Under the terms of the PPP, certain
amounts of the loan may be forgiven if they are used for qualifying expenses. The Company was in compliance with the terms of the PPP
loan as of March 31, 2021.
If
the conditions outlined in the PPP loan program are adhered to by the Company, all or part of such loan could be forgiven. The Company
believes that all or a substantial portion of the PPP loan is eligible for forgiveness. The Company applied for full forgiveness of the
PPP loan on March 17, 2021. As for the potential loan forgiveness, once the PPP loan is, in part or wholly, forgiven and a legal release
is received, the liability would be reduced by the amount forgiven and a gain on extinguishment would be recorded. However, the Company
cannot provide any assurance whether the PPP loan will ultimately be forgiven by the SBA.
8.
Leases Liabilities
The
Company accounts for leases under ASC 842, Leases. The standard requires a lessee to record a right-of-use asset and a corresponding
lease liability at the inception of the lease, initially measured at the present value of the lease payments.
ASC
842 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated
over the lease term, generally on a straight-line basis. During the three months ended March 31, 2021, the Company reflected amortization
of right of use asset of $24 related to these leases, resulting in a net asset balance of $730 as of March 31, 2021.
In
accordance with ASC 842, the right-of-use assets are being amortized over the life of the underlying leases.
As
of December 31, 2020, lease liabilities totaled $685, made up of finance lease liabilities of $16 and operating lease liabilities of
$669. During the three months ended March 31, 2021, the Company terminated $13 of finance leases, and made payments of $2 towards its
finance lease liability and $8 towards its operating lease liability. As of March 31, 2021, lease liabilities totaled $663, made up of
finance lease liability of $1 and operating lease liability of $662.
As
of March 31, 2021, the weighted average remaining lease terms for operating lease and finance lease are 3.76 years and 0.50 years, respectively.
The weighted average discount rate for operating lease is 12.6% and 12.6% for finance lease.
9.
Stock-Based Compensation
Restricted
common stock
The
following table summarizes restricted stock activity during the three months ended March 31, 2021:
Summary of Non-vested Restricted Stock Activity
|
|
Unvested
Shares
|
|
|
Issuable
Shares
|
|
|
Fair Value
at Date of
Issuance
|
|
|
Weighted
Average
Grant Date
Fair Value
|
|
Balance, December 31, 2020
|
|
|
150,000
|
|
|
|
-
|
|
|
$
|
92
|
|
|
|
0.89
|
|
Granted
|
|
|
245,900
|
|
|
|
-
|
|
|
|
226
|
|
|
|
0.92
|
|
Vested
|
|
|
(84,809
|
)
|
|
|
84,809
|
|
|
|
-
|
|
|
|
-
|
|
Forfeited
|
|
|
(2,009
|
)
|
|
|
|
|
|
|
|
|
|
|
0.89
|
|
Issued
|
|
|
-
|
|
|
|
(84,809
|
)
|
|
|
(98
|
)
|
|
|
-
|
|
Balance, March 31, 2021
|
|
|
309,082
|
|
|
|
-
|
|
|
$
|
220
|
|
|
$
|
0.89
|
|
On
January 26, 2021, the board of directors of Reed’s, pursuant to a joint recommendation from its governance and compensation committees,
set the cash compensation of its non-employee directors at $50,000 for fiscal 2021, payable quarterly in accordance with the company’s
policies for non-employee director compensation. In addition, the Company granted 245,900 restricted stock awards to five non-employee
directors. 61,475 of these restricted stock awards vested on February1, 2021. The remaining 184,425 restricted stock awards will vest
equally on May 1, 2021, August 1, 2021, and November 1, 2021. The aggregate fair value of the stock awards was $226 based on the market
price of our common stock price which was $0.92 per share on the date of grants and is amortized as shares vest.
The
total fair value of restricted common stock vesting during the three months ended March 31, 2021 and 2020 was $98
and $285,
respectively, and is included in general and administrative expenses in the accompanying statements of operations. As of March
31, 2021, the amount of unvested compensation related to issuances of restricted common stock was $220,
which will be recognized as an expense in future periods as
the shares vest. When calculating basic loss per share, these shares are included in weighted average common shares outstanding
from the time they vest. When calculating diluted net income per share, these shares are included in weighted average common shares
outstanding as of their grant date.
Stock
options
The
following table summarizes stock option activity during the three months ended March 31, 2021: